It seems now glove stocks lovers start to accept the reality of ASP dropping. Remember many were in denial last year and beginning of this year when commented about the possibility of ASP drop.

As I said this morning homily chart shows bankerchips big players and funds already moved out from all the glove counters including supermx only left the retailers trading now. Without their participation only the retailers involved price can't go up much conversely would drop further as retailers buy now and then panic sell later as price dropping.

Homily chart shows the bankerchips big players and funds already moved out from all the glove counters including supermx only left the retailers trading now, be aware. Whether believe or not, up to u.

RWLV making loss in first one or two years already expected and taken into account by ibs in their grading. It is usual for all new business ventures have loss at its starting and take few years to breakeven. For example Genting Singapore also made loss for few years at its starting but now already turned to profit contribution. We should look and view the new business venture of RWLV for profit contribution in long term as well as creating cash inflow in short term.

Genting won't be bankrupt with 28 billions cash balance and around 30 billions previous earning reserves. It is still be able to survive and sustain for long long time even let say it makes loss 1 billion per year still can last for 28 to 30 years but I don't think pandemic be so long.

Strong support level around $4.80 to $4.9+. It seems very less possibility to drop lower cos most investors and the market seeing and expecting recovery would take place gradually with pandemic would eventually under control.

Let time to present and tell the truth. Wait to see who lies whether u or the medical experts dealing with covid virus lies.

Wake up, don't dream for supermx go up to $10. Ridiculous with high selling pressure from many trapped ones and funds waiting to sell at its upper floors.

It seems many supermx lovers here are very sensitive with the news of vaccines effectiveness or other alternative like pil discovered to cure covid 19, u are much against and hesitate cos u are too worried about supermx stock price can't perform well if the pandemic under control. This show that supermx is a pandemic related stock, its price can't go up much and can't sustain without pandemic.

Read the following to know about the Pil to cure covid 19 within 5 days which expected to be out by end of this year:

https://youtu.be/k_lpx3z2Ajo

Read the following to know about the Pil to cure covid 19 within 5 days which expected to be out by end of this year:

https://youtu.be/k_lpx3z2Ajo

I am not showing out but just clearify it since someone in doubt of other people earning.

Will75, I am now holding 300k shares of Genting bought at average cost $3.10 last year now standing at around $5 and 150k shares of CIMB bought at average cost $3.20 last year now standing around $4.15. If your maths not bad can calculate the paper profit I mentioned. Don't be jealous u also can invest in Genting stocks and CIMB stocks as many as u want.

Kltower 1, I never have heart pain even though I earned only $40k from short trading supermx cos I am enjoying $500k to $600k paper profit in genting stocks and almost $150k paper profit in CIMB stocks.

So much arguement and doubts of vaccines effectiveness, let time to present and tell the truth. Time won't lie. My posting is just based on the news derived from public media like 8TV and CNBC. Whether believe or not up to individual. No need to be so sensitive with the news. I don't think it would much affect supermx as u say it is so good. Be calm and neutral to face the news that derived from

https://youtu.be/SHJGnov-RXk

https://www.cnbc.com/amp/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html

If u are so much against and look bad the vaccines, don't go for vacination.

DJoker89, u are in deniel spreading misleading own assumptions just for the sake of your personal investment aims very selfish not me. I am telling the true news derived from public media like CNBC. Is the CNBC news misleading?

The drop of covid cases in US, United Kindom and Isreal already verified the vaccines are seen effective and does work to control covid virus and the pandemic even through India cases are still serious cos vaccination there not really exercised yet and the mutated varriant is to be overcome by the updated version of vaccines later. Pil is expected to be out by end of this year to treat the covid virus in its first sign.

All these positive developments seem to lead the pandemic worldwide under control by end of this year or latest by next year. As the human being we should have positive look and positive thinking about all these good development for the good of everyone including u, your family members relatives and your friends. Is it?

It seems the supermx lovers are lack of confidence and in doubt of the company still sustain well if pandemic under control. Thus posting about covid cases to maintain self confidence of holding the stock. This show that supermx stock can't perform well in the market without pandemic and it needs pandemic ongoing to maintain its stock performance.

Pill to treat COVID-19 could be available year's end, Pfizer CEO says

Pfizer's experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.
The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.

Pfizer's experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.

The company, which developed the first authorized Covid-19 vaccine in the U.S. with German drugmaker BioNTech, began in March an early stage clinical trial testing a new antiviral therapy for the disease. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.

Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.

If clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed across the U.S. by the end of the year, Bourla told CNBC's "Squawk Box."

Health experts say the drug, taken by mouth, could be a game changer because people newly infected with the virus could use it outside of hospitals. Researchers hope the medication will keep the disease from progressing and prevent hospital trips.

In addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children. Vaccinating children is crucial to ending the coronavirus pandemic, public health officials and infectious disease experts say.

Earlier this month, the company asked the FDA to expand its vaccine authorization to adolescents ages 12 to 15 after the shot was found to be 100% effective in a study.

Bourla told CNBC on Tuesday he is "very optimistic" that the FDA will approve use of the shot in adolescents.

https://www.cnbc.com/amp/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html

Pill to treat COVID-19 could be available year's end, Pfizer CEO says

Pfizer's experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.
The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.

Pfizer's experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.

The company, which developed the first authorized Covid-19 vaccine in the U.S. with German drugmaker BioNTech, began in March an early stage clinical trial testing a new antiviral therapy for the disease. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.

Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.

If clinical trials go well and the Food and Drug Administration approves it, the drug could be distributed across the U.S. by the end of the year, Bourla told CNBC's "Squawk Box."

Health experts say the drug, taken by mouth, could be a game changer because people newly infected with the virus could use it outside of hospitals. Researchers hope the medication will keep the disease from progressing and prevent hospital trips.

In addition to the drug, Pfizer is still testing its vaccine in 6-month to 11-year-old children. Vaccinating children is crucial to ending the coronavirus pandemic, public health officials and infectious disease experts say.

Earlier this month, the company asked the FDA to expand its vaccine authorization to adolescents ages 12 to 15 after the shot was found to be 100% effective in a study.

Bourla told CNBC on Tuesday he is "very optimistic" that the FDA will approve use of the shot in adolescents.

https://www.cnbc.com/amp/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html

Anyway since u are so optimistic and confident about the future glove demand and its ASP, let time to present it we wait to see. Good luck.

liewtz06, u always talk about the glove consumption demand but ignore the production expansion by the existing glove manufacturers and the entry of new manufacturers in the whole world especially in Malaysia, China, Thailand and also US soon that would cause the oversupply of gloves worldwide post pandemic that would lead to gradual drop of ASP which is also predicted by the boss of supermx and even topglove in their statements made.

If US produce gloves on its own to supply 50% of its glove demand, this means that it would cut 50% of its glove import from Malaysia that would definately affect supermx future profit at certain extent.

When vaccines effectively control the pandemic with loosed SOP that people are no need to wear masks already, gloves also won't be common use by people, mostly only for medical use.

US and Isreal covid cases drop under control with loosed SOP and no need to wear masks already verified that vaccines are effective and it does work to control covid virus and the pandemic.

Watch the following 8TV news to know about USA covid cases drop under control that US people no need to wear masks now at outdoor for the loosed SOP:

https://youtu.be/SHJGnov-RXk

Yes if supermx set up plant in US but this is just the proposal so far no news yet. Furthermore what would happen on its plants in Malaysia if less or even no more export to US later.

US and Isreal covid cases drop under control with loosed SOP and no need to wear masks already verified that vaccines are effective and it does work to control covid virus and the pandemic.

Later USA would have its own glove manufacturing supply to fulfill majority of its glove demand that would reduce its glove import from Malaysia.

Watch the following 8TV news to know about USA covid cases drop under control that US people no need to wear masks now at outdoor for the loosed SOP:

https://youtu.be/SHJGnov-RXk

*ISRAEL HAS REACHED HERD IMMUNITY -BBC*

Israel has once again shown countries how clever leaders think in the 2nd and 3rd order (thinking beyond the obvious).*

Last week Israel became the first country to inoculate its entire adult population over age 18. Yesterday, all schools and colleges were opened and mask requirements were removed all across the country (barring a few congested public places).

Here's how this remarkable country did it.

Israel's leaders are all well educated and many of them have advanced degrees in science and medicine. Their PM graduated at the top of his class at MIT, and started (but didn't finish) a PhD at Harvard.

They realized at the onset of the pandemic last year that the only way to beat a virus was through herd immunity, and that vaccination was key to expediting this process. They immediately zeroed in the two companies that were ahead of the pack in vaccine development--Pfizer and Moderna. The Israeli PM immediately developed a personal friendship with the CEOs of these companies (using his Harvard and MIT connections).

As soon as Pfizer announced successful Phase 3 trials Israel made a deal with Pfizer to pick up their first 8 million doses for twice the price ($30 per dose) of what Pfizer was eventually aiming to sell the vaccine. Israel also agreed to provide Pfizer with data on the efficacy of the vaccine on its population. By November 2020, Israel had already acquired the vaccines it required to immunize its people.

The Israeli PM was asked two weeks ago why they agreed to pay $15 per dose extra, and his response was classic 2nd order thinking. He said that, just in pure economic numbers, the total amount they overpaid was a miniscule fraction of what it costs to lockdown the country. This is not counting the extra medical costs of Covid and the incalculable price of losing a loved one. The economic loss from just three days of lockdown was more than the overpayment for all the vaccines they bought.

*This is how smart and educated leaders think and achieve great things for their country*

*ISRAEL HAS REACHED HERD IMMUNITY -BBC*

Israel has once again shown countries how clever leaders think in the 2nd and 3rd order (thinking beyond the obvious).*

Last week Israel became the first country to inoculate its entire adult population over age 18. Yesterday, all schools and colleges were opened and mask requirements were removed all across the country (barring a few congested public places).

Here's how this remarkable country did it.

Israel's leaders are all well educated and many of them have advanced degrees in science and medicine. Their PM graduated at the top of his class at MIT, and started (but didn't finish) a PhD at Harvard.

They realized at the onset of the pandemic last year that the only way to beat a virus was through herd immunity, and that vaccination was key to expediting this process. They immediately zeroed in the two companies that were ahead of the pack in vaccine development--Pfizer and Moderna. The Israeli PM immediately developed a personal friendship with the CEOs of these companies (using his Harvard and MIT connections).

As soon as Pfizer announced successful Phase 3 trials Israel made a deal with Pfizer to pick up their first 8 million doses for twice the price ($30 per dose) of what Pfizer was eventually aiming to sell the vaccine. Israel also agreed to provide Pfizer with data on the efficacy of the vaccine on its population. By November 2020, Israel had already acquired the vaccines it required to immunize its people.

The Israeli PM was asked two weeks ago why they agreed to pay $15 per dose extra, and his response was classic 2nd order thinking. He said that, just in pure economic numbers, the total amount they overpaid was a miniscule fraction of what it costs to lockdown the country. This is not counting the extra medical costs of Covid and the incalculable price of losing a loved one. The economic loss from just three days of lockdown was more than the overpayment for all the vaccines they bought.

*This is how smart and educated leaders think and achieve great things for their country*

It is still long term down trend, this round up is only the rebound for u to release if can. It might be the last chance for u to release. Some are still dreaming for $8 and $10 ridiculous cos high selling pressure from the trapped ones waiting to sell at its upper floor. If the funds selling to move out, the price would drop deeply.

Still dreaming.

Most trapped ones would have a thinking that this rebound might be the last chance for them to release thus they sell even though making little loss when price almost approaches to their purchased price. Less people buying cos they would think if be trapped this time no way to release have to wait untill next new pandemic come. With this kind of phycological thinking, less and weak buying force, price can't go up much.

Whether u called gloverocket or not is up to u. Everything has to see the stock market. Gook luck.

Will75, Even at this moment I don't have any glove stocks but I have traded in supermx and earned almost $40k recently.

Actually I am not creating fear but I am telling the facts. Even u want to make money from glove counters as a smart investor u must realize and accept the facts can't blindly invest. Is'nt it?

Pang72, I no need to make confident in glove stocks cos I am enjoying my paper profit of >$500k in genting share and almost $150k paper profit in CIMB shares that all bought at its bottom part.

Funds can be in and out frequently anytime. Whether the price can stand or not have to depend on the funds. If on one day later funds move out price would drop back again.
Most people now fear of being trapped and losing money don't chase high wait for price drops back to buy low if they want to buy even u also act like that now. If most people act like that and less to chase high plus heavy selling from trapped ones, how the price can go up higher and higher? Thus last year glove stocks mania does'nt repeat anymore in this year even with high covid cases or the 4th wave as u say.

U wish the price to go up higher and higher but it might happen opposed from your wish cos it's determined by the market buying force and selling pressure. Let the market to present, it is out of your control even how much u talk here and wish for the price to go up.

It seems the excellent quarter result can't stimulate buying force cos Kossan already released its 1 billion profit earning but its stock price still can't go up much lack of buying force. With the heavy selling pressure from those trapped ones waiting to release and the weak buying force, glove stocks price nowaday difficult to climb up. This is the reality.

AngTayKor, I did bottom fishing for Genting and also 150k shares CIMB at average cost $3.20 when everyone looked bad it at beginning of last year.

AngTayKor, I am fishing big profit even with the current price already made >$500k paper profit.

Genting is an established company more than half century with strong and solid financial position and excellent reputation. It had encountered and gone through many times of crisis still able to survive and sustain its growth. I strongly believe it can also get through and fast recover from this pandemic crisis. Without this pandemic we can't buy genting at so cheap price.

No fear and no worries of holding genting. I have just topped up another 100k shares at $4.80 few days ago in addition to 300k shares previously bought at average cost $3.10, total holding 400k shares genting now waiting to huat lah.

After the pandemic under control and over, genting would recover very fast and would be cash cow with more and more cash inflow from local and oversea sources. What we need is patience to wait for that.

I can see someone here is very frustrated, desperate, jumping for buy call, seeing the stock price dropping already lost patience. Anyway what u say and act here can't influence the market and stock price movement cos out of your control.

Following is the Homily chart to indicate today outflow of funds from supermx and top glove (the red colour area at bottom part of chart decreasing to indicate funds outflow):

https://youtu.be/XbznoT-LSmA